Ocugen Inc

Ocugen Inc

OCGN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$296.18M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ocugen IncOcugen Inc-2.8-494%--5.2
$-0.30

Current Fair Value

133.8% downside

Overvalued by 133.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$296.18 Million
Enterprise Value$282.38 Million
Earnings per Share$-0.23
Beta2.27
Outstanding Shares338,679,856

Return

Return on Equity494.15%ROE
Return on Assets-65.87%
Return on Invested Capital816.58%

Valuation & Multiples

P/E Ratio-2.78P/E Ratio
PEG-4.05PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.87Price to Book Ratio
Enterprise Value to Revenue61.66
Enterprise Value to EBIT-3.9
Enterprise Value to Net Income-4
Total Debt to Enterprise0.31
Debt to Equity-5.21Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS Estimate
$-0.06
Consensus analyst estimate
Revenue Estimate
$1.32 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 47.01%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.11%▼ 43.17%
Total Invested$368,980▼ 99.84%
Investors Holding10▼ 149.00%

About Ocugen Inc

CEO: Shankar Musunuri

Ocugen Insider Information FAQ

Stockcircle tracks 3 top investors with a current 13F position in Ocugen. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 2 open-market insider sales for Ocugen in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.